INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-I TREATMENT IN THE ADOLESCENT WITH INSULIN-DEPENDENT DIABETES-MELLITUS

被引:26
作者
DUNGER, DB
CHEETHAM, TD
CROWNE, EC
机构
[1] Department of Paediatrics, The John Radcliffe Hospital, University of Oxford, Oxford
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1995年 / 44卷 / 10期
关键词
D O I
10.1016/0026-0495(95)90232-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin-dependent diabetes mellitus (IDDM) during adolescence is associated with complex derangements of the growth hormone (GH)/insulin-like growth factor (IGF) axis. Despite GH hypersecretion, IGF-I levels and IGF bioactivity are reduced. The diabetogenic effects of GH are well established, and GH hypersecretion has been implicated in the deterioration in glycemic control during adolescence and in the development of microangiopathy. Insulin deficiency or reduced portal delivery of insulin plays a central role in the development of these abnormalities, and although continuous subcutaneous insulin delivery may improve plasma IGF-I levels, it does not necessarily suppress GH levels. Recombinant IGF-I has been proposed as an adjunct to conventional insulin therapy, as restoring circulating IGF-I levels might lead to GH suppression. Placebo-controlled studies have shown a consistent reduction in GH secretion and related improvements in insulin sensitivity following a single subcutaneous IGF-I injection (40 mu g/kg). Repeated daily subcutaneous IGF I administration for 1 month resulted in a sustained increase in IGF-I levels, as well as a reduction in GH secretion and insulin requirements. There was no increase in hypoglycemia or other adverse effects. Recombinant IGF I used in conjunction with insulin may therefore provide an additional approach to the management of IDDM during adolescence, allowing correction of abnormalities in the GH/IGF axis and leading to improved control and, hence, reduced risk of long term complications. However, this hypothesis needs to be rigorously tested in long-term placebo controlled studies. Copyright (C) 1995 by W.B. Saunders Company.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 56 条
  • [1] THE ROLE OF GROWTH-HORMONE IN THE DEVELOPMENT OF DIABETIC-RETINOPATHY
    ALZAID, AA
    DINNEEN, SF
    MELTON, LJ
    RIZZA, RA
    [J]. DIABETES CARE, 1994, 17 (06) : 531 - 534
  • [2] EFFECT OF DIABETES AND ITS CONTROL ON INSULIN-LIKE GROWTH-FACTORS IN THE YOUNG SUBJECT WITH TYPE-I DIABETES
    AMIEL, SA
    SHERWIN, RS
    HINTZ, RL
    GERTNER, JM
    PRESS, CM
    TAMBORLANE, WV
    [J]. DIABETES, 1984, 33 (12) : 1175 - 1179
  • [3] IMPAIRED INSULIN ACTION IN PUBERTY - A CONTRIBUTING FACTOR TO POOR GLYCEMIC CONTROL IN ADOLESCENTS WITH DIABETES
    AMIEL, SA
    SHERWIN, RS
    SIMONSON, DC
    LAURITANO, AA
    TAMBORLANE, WV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) : 215 - 219
  • [4] ABNORMAL GROWTH-HORMONE LEVELS IN INSULIN-DEPENDENT DIABETIC-PATIENTS UNDER CONTINUOUS SUBCUTANEOUS INSULIN INFUSION AND INTENSIFIED CONVENTIONAL TREATMENT
    ARIAS, P
    KERNER, W
    DELAFUENTE, A
    PFEIFFER, EF
    [J]. ACTA ENDOCRINOLOGICA, 1984, 107 (02): : 250 - 255
  • [5] CIRCULATING INSULIN-LIKE GROWTH FACTOR-I IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH RETINOPATHY
    ARNER, P
    SJOBERG, S
    GJOTTERBERG, M
    SKOTTNER, A
    [J]. DIABETOLOGIA, 1989, 32 (10) : 753 - 758
  • [6] THE DAWN PHENOMENON - COMPARISON BETWEEN NORMAL AND INSULIN-DEPENDENT DIABETIC ADOLESCENTS
    ARSLANIAN, S
    OHKI, Y
    BECKER, DJ
    DRASH, AL
    [J]. PEDIATRIC RESEARCH, 1992, 31 (03) : 203 - 206
  • [7] INSULIN THERAPY INCREASES LOW PLASMA GROWTH-HORMONE BINDING-PROTEIN IN CHILDREN WITH NEW-ONSET TYPE-1 DIABETES
    ARSLANIAN, SA
    MENON, RK
    GIERL, AP
    HEIL, BV
    FOLEY, TP
    [J]. DIABETIC MEDICINE, 1993, 10 (09) : 833 - 838
  • [8] BALLARD J, 1992, J CLIN ENDOCR METAB, V74, P1215
  • [9] ABNORMAL REGULATION OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN ADOLESCENTS WITH INSULIN-DEPENDENT DIABETES
    BATCH, JA
    BAXTER, RC
    WERTHER, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05) : 964 - 968
  • [10] SOMATOGENIC RECEPTORS OF RAT-LIVER - REGULATION BY INSULIN
    BAXTER, RC
    BRYSON, JM
    TURTLE, JR
    [J]. ENDOCRINOLOGY, 1980, 107 (04) : 1176 - 1181